Alternative methods to the standard clinical trial are mentioned to place them in perspective for overall evaluation of dry eye disease therapy.
Attempts to avoid missing data before and during the trial were mentioned in 26 trials.
Molecular abnormalities for which no MTA was available in the frame of the SHIVA trial but that were relevant to guide the patient in a clinical trial were mentioned in the molecular report but not considered druggable for the trial.
Three other randomised trials are mentioned in the Cochrane Review (Gøtzsche and Nielsen, 2011), but were excluded because they compared multiple interventions (not just mammography), or made major post-randomisation exclusions.
Sorry" Trial acceptability was mentioned as a reason for non-participation some inon-participation somehe duratindividualsuency ofelte thatl was notheractical, anduration did nor want to take part as there was potential to not receive the intervention ofrequencyscan.
Trial registration was mentioned in thirteen of the 41 journals (32%), out of which nine required and four recommended trial registration prior to publication of a manuscript (Table 1).
During Hardman's trial it was mentioned by a witness that he had once smoked cannabis, some years before the murder.
This issue was a particular problem since it was felt that patients were more likely to take part in the trial if it was mentioned to them by a member of medical staff.
She was widely described by reporters as "calm" and "stolid" in facing the court and only cried once during the trial, when her son was mentioned.
Avoidance of cointerventions by trial design or monitoring of the use of cointerventions was mentioned in five trials.
